Dr. Gallagher is an advocate for the advancement of immunotherapy, or the use of the patient's own immune system in order to treat breast cancer, as well as targeted therapy derived from the genetic sequencing of breast tumors in order to detect abnormalities that may indicate a response from a specific drug..